Inflammatory bowel diseases

Inflamm Bowel Dis · ISSN (e) 1536-4844 · 12 papers in corpus
2024
doi:10.1093/ibd/izae024 ·PMID:38459910

BackgroundMirikizumab, a p19-directed interleukin-23 monoclonal antibody, is efficacious in inducing clinical remission at week 12 (W12) and maintaining clinical remission at W52 in patients with moderately to severely active ulcerative col…

letter 2021
doi:10.1093/ibd/izaa345 ·PMID:33393611

To the editors, Endometriosis is a chronic disease that affects approximately 10% of women. Gastrointestinal symptoms are frequent in patients with endometriosis; indeed, the bowel is the main site for endometriosis outside the genital trac…

2016
doi:10.1097/mib.0000000000000884 ·PMID:27537054

The incidence and prevalence of inflammatory bowel disease (IBD) continues to rise with time, signifying its emergence as a global disease. Clinical onset of IBD, comprising Crohn's disease and ulcerative colitis, typically occurs before or…

2016
doi:10.1097/mib.0000000000000818 ·PMID:27243591

Inflammatory bowel disease (IBD) is an inflammatory disorder of the intestine that affects an estimated 329 per 100,000 people in the United States and is increasing in incidence within a number of cultures worldwide. Likely due to its inco…

2016
doi:10.1097/mib.0000000000000606 ·PMID:26484636

Women with chronic medical conditions, such as inflammatory bowel diseases, are at increased risk for adverse pregnancy outcomes. Pregnancy outcomes for these conditions are best during stable disease remission. Unfortunately, women with in…

article 2015
doi:10.1097/mib.0000000000000577 ·PMID:26332310

BACKGROUND: Inflammatory bowel disease (IBD) and endometriosis are immune-mediated chronic inflammatory disorders affecting young women. The clinical significance of concomitant endometriosis on the course of IBD has not been previously stu…

article 2014
doi:10.1097/01.mib.0000441347.94451.cf ·PMID:24451220

BACKGROUND: The effect of the inflammatory bowel diseases (IBD) on menstrual function is largely unknown. The aims of this study were to determine whether changes in menstrual function occur in the year before IBD diagnosis or in the initia…

2014
doi:10.1097/mib.0000000000000134 ·PMID:25105949

BackgroundWomen with inflammatory bowel diseases (IBD) commonly report an increase in their IBD symptoms related to their menstrual cycle. Hormonal contraceptives are safe for women with IBD and frequently used for reproductive planning, bu…

2013
doi:10.1097/mib.0b013e318281f3a9 ·PMID:23598814

BackgroundDysmenorrhea and Crohn's disease (CD) have overlapping symptoms; however, their relationship is poorly understood. The aims of this study were to examine (1) the impact of dysmenorrhea on pain severity and pain medication use in C…

2013
doi:10.1097/mib.0b013e318281341b ·PMID:23567780

BackgroundFemale patients receiving immunosuppressive therapy may be at increased risk for human papillomavirus (HPV) infection and cervical neoplasia.MethodsWe administered the 3-dose HPV vaccine Gardasil to 37 females aged 9 to 26 years w…

letter 2012
doi:10.1002/ibd.22987 ·PMID:23292351

Jess Jess T T Frisch Frisch M M Jørgensen Jørgensen KT KT . Increased risk of inflammatory bowel disease in women with endometriosis: a nationwide Danish cohort study Increased risk of inflammatory bowel disease in women with endometriosis:…

2010
doi:10.1002/ibd.21267 ·PMID:20848482

BackgroundCrohn's disease (CD) and ulcerative colitis (UC) are associated with expression differences in genes involved in immune function, wound healing, and tissue remodeling. MicroRNAs (miRNAs) are small, noncoding RNAs that act as poten…